Target type: biologicalprocess
The chemical reactions and pathways resulting in the formation of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine. [GOC:mah, ISBN:0198506732]
The hyaluronan biosynthetic process is a complex and vital pathway that produces hyaluronan, a large, unbranched glycosaminoglycan (GAG) with crucial roles in various biological processes. Here's a detailed description:
**1. Substrate Preparation:**
- The starting point is the intracellular synthesis of UDP-glucuronic acid (UDP-GlcA) and UDP-N-acetylglucosamine (UDP-GlcNAc), the building blocks of hyaluronan.
- These precursor molecules are generated through separate metabolic pathways.
**2. Hyaluronan Synthase (HAS) Activity:**
- The key enzyme responsible for hyaluronan synthesis is hyaluronan synthase (HAS). There are three HAS isoforms (HAS1, HAS2, and HAS3) in mammals, each with distinct tissue distribution and regulatory properties.
- HAS enzymes reside in the plasma membrane, with their active site facing the extracellular space.
**3. Alternating Addition of Monomers:**
- HAS utilizes UDP-GlcA and UDP-GlcNAc as substrates, adding them alternately to the growing hyaluronan chain.
- The reaction involves the transfer of GlcA and GlcNAc from their UDP conjugates to the non-reducing end of the growing hyaluronan chain, forming β-1,4-glycosidic bonds.
**4. Chain Elongation:**
- The process continues, with HAS repeatedly adding GlcA and GlcNAc units, leading to the formation of a long, unbranched hyaluronan chain.
- The chain can reach molecular weights exceeding millions of Daltons.
**5. Extrusion into the Extracellular Matrix:**
- Hyaluronan, as it's synthesized by HAS, is directly extruded through the plasma membrane into the extracellular space.
- This extrusion is coupled to chain elongation, ensuring that the hyaluronan polymer is continuously added to the growing chain.
**6. Hyaluronan Interactions:**
- Once in the extracellular matrix, hyaluronan interacts with various proteins, forming complex structures and influencing tissue organization.
- It can interact with other GAGs, proteoglycans, and structural proteins, forming a complex and hydrated matrix that provides support, lubrication, and signaling cues.
**7. Regulation of Hyaluronan Biosynthesis:**
- The synthesis of hyaluronan is tightly regulated by various factors, including growth factors, cytokines, and mechanical stimuli.
- The expression and activity of HAS enzymes can be modulated by these factors, controlling the amount and properties of hyaluronan produced.
**8. Biological Functions of Hyaluronan:**
- Hyaluronan is a versatile molecule with diverse biological functions, including:
- **Structural support and tissue organization:** Hyaluronan contributes to the integrity and elasticity of tissues, particularly connective tissues, joints, and skin.
- **Lubrication and joint function:** Hyaluronan acts as a lubricant in joints, facilitating smooth movement and reducing friction.
- **Cell signaling and migration:** Hyaluronan interacts with cell surface receptors, influencing cell behavior, adhesion, and migration during development and wound healing.
- **Inflammation and wound healing:** Hyaluronan plays roles in inflammation, acting as a signaling molecule and influencing immune cell recruitment and tissue repair.
- **Cancer progression:** Hyaluronan is implicated in tumor growth, metastasis, and angiogenesis.
**Conclusion:**
The hyaluronan biosynthetic process is a crucial pathway for producing a vital glycosaminoglycan that contributes to a multitude of cellular and tissue functions. Its intricate regulation and diverse roles make it a critical factor in maintaining tissue homeostasis and influencing various biological processes.'
"
Protein | Definition | Taxonomy |
---|---|---|
Multidrug resistance-associated protein 5 | An ATP-binding cassette sub-family C member 5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O15440] | Homo sapiens (human) |
Hyaluronidase-1 | A hyaluronidase-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q12794] | Homo sapiens (human) |
Interleukin-1 beta | An interleukin-1 beta that is encoded in the genome of human. [PRO:CNA, UniProtKB:P01584] | Homo sapiens (human) |
Multidrug resistance-associated protein 5 | An ATP-binding cassette sub-family C member 5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O15440] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
dilazep | dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties. Dilazep: Coronary vasodilator with some antiarrhythmic activity. | benzoate ester; diazepane; diester; methoxybenzenes | cardioprotective agent; platelet aggregation inhibitor; vasodilator agent |
dipyridamole | dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots. Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) | piperidines; pyrimidopyrimidine; tertiary amino compound; tetrol | adenosine phosphodiesterase inhibitor; EC 3.5.4.4 (adenosine deaminase) inhibitor; platelet aggregation inhibitor; vasodilator agent |
sulfinpyrazone | Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. | pyrazolidines; sulfoxide | uricosuric drug |
trequinsin | trequinsin: RN given refers to parent cpd; structure given in first source | pyridopyrimidine | |
ferulic acid | ferulate : A monocarboxylic acid anion obtained by the deprotonation of the carboxy group of ferulic acid. | ferulic acids | anti-inflammatory agent; antioxidant; apoptosis inhibitor; cardioprotective agent; MALDI matrix material; plant metabolite |
caffeic acid | trans-caffeic acid : The trans-isomer of caffeic acid. | caffeic acid | geroprotector; mouse metabolite |
isoferulic acid | isoferulic acid : A ferulic acid consisting of trans-cinnamic acid bearing methoxy and hydroxy substituents at positions 4 and 3 respectively on the phenyl ring. isoferulic acid: isomer of ferulic acid; structure | ferulic acids | antioxidant; biomarker; metabolite |
rosmarinic acid | (R)-rosmarinic acid : A stereoisomer of rosmarinic acid having (R)-configuration. rosmarinic acid : The 1-carboxy-2-(2,4-dihydroxyphenyl)ethyl ester of trans-caffeic acid. rosmarinic acid: RN given refers to parent cpd; promote OT project | rosmarinic acid | geroprotector; plant metabolite |
l 660,711 | quinolines | ||
n-acetyltyrosyl-valyl-alanyl-aspartyl aldehyde | |||
berkeleydione | berkeleydione : A meroterpenoid found in Penicillium rubrum. It has been shown to exhibit inhibitory activity against caspase-1. berkeleydione: polyketide-terpenoid metabolite, isolated from a Penicillium sp.; structure in first source | beta-diketone; cyclic terpene ketone; meroterpenoid; methyl ester; organic heterotetracyclic compound; terpene lactone; tertiary alcohol; tertiary alpha-hydroxy ketone | antineoplastic agent; cysteine protease inhibitor; Penicillium metabolite |
cyclic gmp | 3',5'-cyclic GMP : A 3',5'-cyclic purine nucleotide in which the purine nucleobase is specified as guanidine. Cyclic GMP: Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) | 3',5'-cyclic purine nucleotide; guanyl ribonucleotide | Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite |
sildenafil | sildenafil : A pyrazolo[4,3-d]pyrimidin-7-one having a methyl substituent at the 1-position, a propyl substituent at the 3-position and a 2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl group at the 5-position. | piperazines; pyrazolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |